How life sciences companies can manage supply chain disruptions

Author : management consulting | Published On : 06 May 2026

Supply chains are the backbone of the global economy. However, disruptions in supply chains are common and often unavoidable. Pandemics, extreme weather, economic sanctions and armed conflicts have all affected supply chains in the past. On the other hand, factors such as climate change, changing lifestyles, raw material shortages, trade conflicts and geopolitical tensions are making these disruptions more likely in the future.

For life sciences companies, these challenges can have serious consequences. It can delay production and affect the availability of critical medicines and healthcare products. This is why building resilient supply chains with the help of life science supply chain consulting has become a top priority for many organizations.

Main causes behind supply chain disruptions in life sciences

Here are some factors that can contribute to making life sciences supply chains vulnerable:

• Demand volatility: Customer demand and needs are changing quickly, which makes it important for life sciences companies to closely monitor market trends and buying patterns. Soon, global events, copycat products and company mergers will make this a bigger issue.

• Supply uncertainty: For better efficiency, supply chains have focused on getting larger supplier contracts, offshore sourcing of key raw materials and outsourcing parts of their supply chain to third parties. While these strategies can reduce costs, they can also make supply chains more fragile.

• Distributed manufacturing facilities: Many life sciences companies have expanded operations to countries with lower labor and production costs. While this shift offers a great financial advantage, it also exposes supply chains to new risks. Geopolitical tensions, natural disasters and international sanctions can all disrupt manufacturing activities and impact supply chain stability.

• Disconnected logistics networks: When key routes get blocked, it can stop the movement of materials and finished goods. Even small delays can cause problems, affecting a company's reputation.

Beyond these challenges, life sciences supply chains also face risks from factors such as:

• Shortages of raw materials, parts, and packaging

• Weak infrastructure, like power, water, and utilities

• Cybersecurity threats

• Emergencies blocking factories or warehouses

• Contractors not delivering on time

The whack-a-mole effect on the supply chain

When life sciences companies try to fix one problem in their supply chain, it often creates another problem. For example, storing raw materials can reduce supplier risk, but it also increases costs. Manufacturing in safer regions can help avoid disasters, but it also increases transport expenses. Shipping by air can avoid port delays, but it can be expensive. 

This “whack‑a‑mole” effect shows why companies need a structured plan instead of patchwork solutions.

How to build resilience?

Following risk management plans (RMPs) can help companies identify, prioritize, and reduce risks and build resilience for the supply chain.

These plans may include training employees to take on multiple roles, creating flexible transportation routes, developing clear crisis response strategies and using digital tools to share information quickly.

By narrowing the gap between actual risk and acceptable risk, along with help from biotech consulting, companies can keep medicines flowing even during disruptions.

Overall, disruptions will always pose a challenge in supply chains, especially in life sciences. However, you don’t have to let them win. By focusing on resilience, improving visibility, and planning ahead, companies can be better prepared. In the long run, this ensures that critical medicines and therapies reach patients without unnecessary delays.